Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

National Vision Holdings Inc (EYE)

National Vision Holdings Inc (EYE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,672,606
  • Shares Outstanding, K 79,118
  • Annual Sales, $ 1,537 M
  • Annual Income, $ 23,650 K
  • 60-Month Beta 1.59
  • Price/Sales 1.64
  • Price/Cash Flow 22.71
  • Price/Book 3.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.07
  • Number of Estimates 1
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year -0.06
  • Growth Rate Est. (year over year) -16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.41 +11.56%
on 01/03/20
35.33 -0.82%
on 01/22/20
+2.04 (+6.18%)
since 12/20/19
3-Month
22.70 +54.36%
on 10/23/19
35.33 -0.82%
on 01/22/20
+11.72 (+50.26%)
since 10/22/19
52-Week
22.02 +59.13%
on 10/08/19
35.66 -1.74%
on 02/27/19
+3.07 (+9.60%)
since 01/22/19

Most Recent Stories

More News
America's Best Contacts & Eyeglasses Expands Partnership With Privé Revaux To All Retail Locations

Privé Revaux, the affordable celebrity eyewear brand that exploded onto the scene two years ago, is continuing its massive retail expansion and exclusive optical partnership with America's Best Contacts...

EYE : 35.04 (+3.73%)
Teleflex Hits New 52-Week High: What's Driving the Rally?

Teleflex (TFX) is optimistic about maintaining growth momentum on several recent developments.

TFX : 386.35 (+0.63%)
MDT : 121.09 (+0.64%)
HAE : 115.61 (+0.16%)
EYE : 35.04 (+3.73%)
Thermo Fisher Rides on New Product Suite, Currency Woes Stay

Thermo Fisher Scientific (TMO) recently unveils a product suite comprising the TSQ Altis, Quantis MD mass spectrometers and Vanquish MD HPLC.

TMO : 340.05 (+0.83%)
MDT : 121.09 (+0.64%)
HAE : 115.61 (+0.16%)
EYE : 35.04 (+3.73%)
Masimo's Neonatal RD SET Pulse Oximetry Sensors Get FDA Nod

Masimo (MASI) will cater to the whole prenatal patient population, with the recent FDA clearance within the SET pulse oximetry business.

MASI : 171.06 (-1.51%)
MDT : 121.09 (+0.64%)
HAE : 115.61 (+0.16%)
EYE : 35.04 (+3.73%)
Hologic (HOLX) Divests Cynosure to Focus on Women's Health

Hologic (HOLX) expects to witness favorable outcomes from the sell-off of the Cynosure medical aesthetics business, which was its loss-making arm since 2017.

HOLX : 54.24 (+0.06%)
MDT : 121.09 (+0.64%)
HAE : 115.61 (+0.16%)
EYE : 35.04 (+3.73%)
Here's Why You Should Add NuVasive Stock to Your Portfolio

Investors continue to be optimistic about NuVasive (NUVA) on its stellar segmental performance in Q3.

MDT : 121.09 (+0.64%)
NUVA : 77.88 (+0.23%)
HAE : 115.61 (+0.16%)
EYE : 35.04 (+3.73%)
Edwards (EW) Rides on Innovation Despite Regulatory Issues

Edwards Lifesciences' (EW) HemoSphere all-in-one monitoring platform is gaining momentum on the back of a strong rollout that sees a full-market launch.

EW : 242.99 (+0.36%)
HAE : 115.61 (+0.16%)
NUVA : 77.88 (+0.23%)
EYE : 35.04 (+3.73%)
Product Launches Aid Intersect ENT (XENT) Despite Cost Woes

Intersect ENT (XENT) recently closes its ENCORE study, a small 50-patient open label program designed to evaluate the safety of the repetitive use of SINUVA.

XENT : 25.17 (+4.66%)
RMD : 164.38 (+1.51%)
HAE : 115.61 (+0.16%)
EYE : 35.04 (+3.73%)
Bruker (BRKR) Rides High on Strong Nano Sales, New Buyouts

Bruker (BRKR) is reaping solid synergy benefits from the acquisitions of Anasys, JPK and Alicona.

BRKR : 53.19 (-0.08%)
HAE : 115.61 (+0.16%)
RMD : 164.38 (+1.51%)
EYE : 35.04 (+3.73%)
Neogen (NEOG) Q2 Earnings & Revenues Miss, Margin Rises

Neogen Corporation (NEOG) disappoints investors with dismal second-quarter fiscal 2020 results. However, the Food Safety segment showcased a robust performance.

HAE : 115.61 (+0.16%)
NEOG : 69.86 (+0.81%)
RMD : 164.38 (+1.51%)
EYE : 35.04 (+3.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade EYE with:

Business Summary

National Vision Holdings, Inc. is involved in optical retail primarily in the United States. The company offer product and services for eye care needs through retail stores and consumer websites. Its brand portfolio consists of America's Best Contacts & Eyeglasses, Eyeglass World, Vision Centers inside...

See More

Key Turning Points

2nd Resistance Point 36.23
1st Resistance Point 35.64
Last Price 35.04
1st Support Level 34.14
2nd Support Level 33.23

See More

52-Week High 35.66
Last Price 35.04
Fibonacci 61.8% 30.45
Fibonacci 50% 28.84
Fibonacci 38.2% 27.23
52-Week Low 22.02

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar